-
hcup-us.ahrq.gov/reports/methods/1998ChangesintheNISRedesignFinal.pdf
January 18, 2002 - MAINTAIN AND EXPAND
HCUP Methods Series
kbr33831
Contact Information:
Healthcare Cost and Utilization Project (HCUP)
Agency for Healthcare Research and Quality
540 Gaither Road
Rockville, MD 20850
http://www.hcup-us.ahrq.gov
For Technical Assistance with HCUP Products:
Email: hcup@ahrq.gov …
-
www.ahrq.gov/sites/default/files/wysiwyg/cahps/quality-improvement/reports-and-case-studies/Case_Study_Specialty_Practice_Updated.pdf
October 01, 2011 - Improving Customer Service and Access in a Surgical Practice
WORKING
P A P E R
Improving Customer
Service and Access in a
Surgical Practice
A Case Study of a Successful
Quality Improvement Intervention
Denise D. Quigley, Shelley H.
Wiseman, and Donna O. Farley
WR-848-AHRQ
August 2011
Prepared for th…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/system/systemredesignsafetynet/systemredesign.pdf
June 01, 2015 - System Redesign Responses to Challenges in Safety-Net Systems
System Redesign Responses to
Challenges in Safety-Net Systems:
Summary of Field Study Research
Submitted to:
Agency for Healthcare Research and Quality
540 Gaither Road
Rockville, MD 20850
www.ahrq.gov
AHRQ ACTION II Contract No. H…
-
effectivehealthcare.ahrq.gov/sites/default/files/celiac-disease_executive.pdf
January 01, 2016 - • Clinical outcomes and complications related to CD? … advice on gluten-free diet
• Followup and monitoring by physician
For KQ 1c, for clinical outcomes and complications
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-analogues-disposition-081229.pdf
September 01, 2008 - and more costly to do the
studies, and more risky to do the studies (e.g. in patients with multiple complications … Further, what we do have is A1c as a surrogate marker for the long term complications.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label-update_executive.pdf
September 01, 2011 - Key Question 4: What are the potential adverse effects
and/or complications involved with off-label prescribing … Key Question 4:What are the potential adverse effects
and/or complications involved with off-label
prescribing
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-0232-fullreport.pdf
February 01, 2020 - obesity are recognized as major medical and public health problems
associated with serious medical complications … Given the vulnerability of obese children to serious physical and emotional complications, the
case
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-230-fullreport.pdf
July 01, 2019 - obesity are recognized as major medical and public health problems
associated with serious medical complications … Weight Classification
Given the vulnerability of obese children to serious physical and emotional complications
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2014chartbooks/womenhealth/2014nhqdr-womenhealth.pptx
January 01, 2020 - outpatient care can prevent the need for hospitalization or for which early intervention can prevent complications … outpatient care can prevent the need for hospitalization or for which early intervention can prevent complications
-
www.ahrq.gov/sites/default/files/2024-05/gore-report.pdf
January 01, 2024 - Identifying the individual’s experiences, goals, and potential future complications early in the disease … She was
also at high risk for complications from alternative treatment options, including uteroscopy
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_executive.pdf
October 01, 2012 - plasma glucose
≥126 mg/dL (7.0 mmol/L), glycated hemoglobin (HbA1c)
≥6.5 percent (Diabetes Chronic Complications … These gaps included lack of
sufficient evidence to determine whether maternal or fetal
complications … Definition, diagnosis and
classification of diabetes mellitus and its complications.
-
hcup-us.ahrq.gov/db/nation/nis/NISIntroduction2010.pdf
November 01, 2015 - , (1)
Comorbidity is present
CM_DMCX 2002-2010 AHRQ comorbidity measure: Diabetes with chronic
complications … Subclass: (0) No class specified,(1) Minor loss of
function (includes cases with no comorbidity or
complications … respiratory system, (9)
Diseases of the digestive system, (10) Diseases of
the genitourinary system, (11) Complications
-
hcup-us.ahrq.gov/db/nation/nis/NIS_2009_INTRODUCTION.pdf
January 01, 2009 - , (1)
Comorbidity is present
CM_DMCX 2002-2009 AHRQ comorbidity measure: Diabetes with chronic
complications … Subclass: (0) No class specified,(1) Minor loss of
function (includes cases with no comorbidity or
complications … respiratory system, (9)
Diseases of the digestive system, (10) Diseases of
the genitourinary system, (11) Complications
-
hcup-us.ahrq.gov/db/nation/nis/NIS_Introduction_2011.pdf
January 01, 2011 - , (1)
Comorbidity is present
CM_DMCX 2002-2011 AHRQ comorbidity measure: Diabetes with chronic
complications … Subclass: (0) No class specified,(1) Minor loss of
function (includes cases with no comorbidity or
complications … respiratory system, (9)
Diseases of the digestive system, (10) Diseases of
the genitourinary system, (11) Complications
-
hcup-us.ahrq.gov/db/nation/nis/reports/NIS_2012_Redesign_report.jsp
January 01, 2012 - Comorbidity is present
Keep
CM_DMCX
2002-2011
AHRQ comorbidity measure: Diabetes with chronic complications … Subclass: (0) No class specified,(1) Minor loss of function (includes cases with no comorbidity or complications … respiratory system, (9) Diseases of the digestive system, (10) Diseases of the genitourinary system, (11) Complications
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/diabetes-1.pdf
March 01, 2020 - Chapter-8 - Diabetes
Harms Due to Diabetic Agents 8-1
8. Harms Due to Diabetic Agents
Authors: Lisa LeRoy Ph.D., M.B.A., and Sonja Richard, M.P.H.
Reviewer: Shelia Roman, M.D.
Introduction
In this chapter, two different kinds of diabetes patient safety practices are addressed—both intended to
improve diabete…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening-1996
January 01, 1996 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
Human Immunodeficiency Virus (HIV) Infection: Screening, 1996
January 01, 1996
Recommendations made by the USPSTF are independen…
-
effectivehealthcare.ahrq.gov/sites/default/files/c-difficile-update_disposition-comments.pdf
March 29, 2016 - Disposition of Comments for CER 172 Clostridium Difficile Diagnosis Prevention Treatment
Comparative Effectiveness Review Disposition of Comments Report
Research Review Title: Early Diagnosis, Prevention, and Treatment of Clostridium difficile:
Update
Draft review available for public comment from April 20, 2015…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
April 18, 2013 - Disposition of Comments for Migraine in Adults: Preventive Pharmacologic Treatments
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Migraine in Adults: Preventive Pharmacologic Treatments
Draft review available for public comment from April 12, 2012 to May …
-
digital.ahrq.gov/sites/default/files/docs/TRANSCRIPT%20OF%20LEVERAGING%20HEALTH%20INFORMATION%20TECHNOLOGY%20FOR%20PATIENT%20EMPOWERMENT_1.pdf
April 08, 2010 - C:\Users\yemsrach dessalegn\Desktop\delete\transcript3.html
TRANSCRIPT OF LEVERAGING HEALTH INFORMATION TECHNOLOGY FOR PATIENT EMPOWERMENT
April 8, 2010
MALE SPEAKER: Welcome to today’s webinar on Leveraging Health Information Technology for Patient
Empowerment. I would like to introduce today's moderator, Dr. Tere…